Federal Register / Vol. 66, No. 37 / Friday, February 23, 2001 / Notices 11305

Dated: February 13, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4459 Filed 2–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Library of Medicine; Notice of

Meeting

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

PubMed Central National Advisory

Committee.

The meeting will be open to the

public, with attendance limited to space

available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

Name of Committee: PubMed Central

National Advisory Committee.

Date: March 21, 2001.

Time: 8:30 a.m. to 4 p.m.

Agenda: Review of Redesignated PMC

System.

Place: National Library of Medicine, Board

Room, Bldg. 38, 2E–09, 8600 Rockville Pike,

Bethesda, MD 20894.

Contact Person: David J. Lipman, MD,

Director, Natl. Ctr. for Biotechnology

Information, National Library of Medicine,

Department of Health and Human Services,

Bethesda, MD 20894.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.879, Medical Library

Assistance, National Institutes of Health,

HHS)

Dated: February 13, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4460 Filed 2–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Meeting of the Recombinant DNA

Advisory Committee

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Recombinant DNA Advisory Committee

(RAC) and a Safety Symposium on Gene

Transfer Research.

The Safety Symposium on Gene

Transfer Research will be held from 8

a.m. to 6 p.m. on March 7, 2001 at the

Doubletree Hotel, 1750 Rockville Pike,

Rockville, MD 20852. The symposium

will explore safety considerations in the

Use of Adeno-Associated Virus Vectors

in Gene Transfer Clinical Trials.

The RAC meeting will be held from

8:30 a.m. to 5:30 p.m. on March 8, 2001

at the National Institutes of Health

(NIH), Building 31, C Wing, Conference

Room 10, 9000 Rockville Pike,

Bethesda, MD 20892. The Committee

will review selected human gene

transfer protocols; a proposed action to

amend the NIH Guidelines with regard

to NIH policy on serious adverse event

reporting; data management activities

related to human gene transfer clinical

trials; and other matters to be

considered by the Committee.

Both meetings are open to the public

with attendance limited to space

available. Draft meeting agendas and

other information will be posted at the

Office of Biotechnology Activities’

website: http://www4.od.nih.gov/oba

Individuals who wish to provide

public comments or who plan to attend

the meeting and need special assistance,

such as sign language interpretation or

other reasonable accommodations,

should notify Kelly Fennington,

Program Analyst, Office of

Biotechnology Activities by telephone at

301 496–9838 or E-mail at

FenningK@od.nih.gov

Dated: February 13, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4455 Filed 2–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: February 28, 2001.

Time: 2:00 p.m. to 4:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Victor A. Fung, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institute of

Health, 6701 Rockledge Drive, Room 4120,

MSC 7804, Bethesda, MD 20892, 301–435–

3504, fungv@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 2, 2001.

Time: 12:00 p.m. to 2:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: John Bishop, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5180,

MSC 7844, Bethesda, MD 20892, (301) 435–

1250.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 6, 2001.

Time: 1:00 p.m. to 2:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Syed Quadri, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4144,

MSC 7804, Bethesda, MD 20892, (301) 435–

1211.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 6, 2001.

Time: 12:00 p.m. to 1:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Daniel R. Kenshalo, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5176,

MSC 7844, Bethesda, MD 20892, 301–435–

1255.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 8–9, 2001.

Time: 8:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 8120 Wisconsin

Avenue, Bethesda, MD 20814.

11306 Federal Register / Vol. 66, No. 37 / Friday, February 23, 2001 / Notices

Contact Person: Bill Bunnag, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5124,

MSC 7854, Bethesda, MD 20892–7854, (301)

435–1177, bunnagb@csr.nih.gov.

Name of Committee: Pathophysiological

Sciences Integrated Review Group,

Respiratory and Applied Physiology Study

Section.

Date: March 8–9, 2001.

Time: 8:30 a.m. to 3:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: St. James Hotel, 950 24th Street

NW., Washington, DC 20037.

Contact Person: Everett E. Sinnett, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 2178,

MSC 7818, Bethesda, MD 20892, (301) 435–

1016, sinnett@nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 8–9, 2001.

Time: 8:30 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Clarion Hampshire Hotel, 1310 New

Hampshire Ave, NW., Washington, DC

20036.

Contact Person: Jay Joshi, PhD, Scientific

Review Administrator, Center for Scientific

Review, National Institutes of Health, 6701

Rockledge Drive, Room 5184, MSC 7846,

Bethesda, MD 20892, (301) 435–1184.

Name of Committee: Center for Scientific

Review Emphasis Panel.

Date: March 8–9, 2001.

Time: 8:30 a.m. to 4:00 p.m.

Agenda: To review and evalaute grant

applications.

Place: Holiday Inn—Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Cathleen L. Cooper, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4208,

MSC 7812, Bethesda, MD 20892, 301–435–

3566, cooperc@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 8–9, 2001.

Time: 8:30 a.m. to 4:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: The River Inn, 924 25th Street,

Washington, DC 20037.

Contact Person: Gloria B. Levin, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3166,

MSC 7848, Bethesda, MD 20892, (301) 435–

1017, leving@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 8–9, 2001.

Time: 9:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Georgetown Suites, 1000 29th St.,

NW., Washington, DC 20007.

Contact Person: Thomas A. Tatham, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3188,

MSC 7848, Bethesda, MD 20892, (301) 435–

0692, tathamt@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 8, 2001.

Time: 9:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, Select, 480 King Street,

Old Town Alexandria, VA 22314.

Contact Person: Yvette M. Davis, VMD,

MPH, Scientific Review Administrator,

Center for Scientific Review, National

Institutes of Health, 6701 Rockledge Drive,

Room 3152, MSC 7770, Bethesda, MD 20892,

301–435–0906.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 8, 2001.

Time: 10:00 a.m. to 1:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Michael Oxman, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4112,

MSC 7848, Bethesda, MD 20892, 301/435–

3565, oxmann@mail.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 8–9, 2001.

Time: 1:00 p.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Quality Hotel, Courthouse Plaza,

1200 North Courthouse Road, Arlington, VA

22201.

Contact Person: Nancy Shinowara, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4208,

MSC 7814, Bethesda, MD 20892–7814, (301)

435–1173, shinowan@drg.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 8, 2001.

Time: 1:30 p.m. to 2:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: St. James Hotel, 950 24th Street,

NW., Washington, DC 20037.

Contact Person: Everett E. Sinnett, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 2178,

MSC 7818, Bethesda, MD 20892, (301) 435–

1016, sinnett@nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 8, 2001.

Time: 12:00 p.m. to 1:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: John Bishop, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5180,

MSC 7844, Bethesda, MD 20892, (301) 435–

1250.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 9, 2001.

Time: 8:00 a.m. to 4:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: The Virginian Suites, 1500

Arlington Blvd., Arlington, VA 22209.

Contact Person: Nancy Hicks, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3158,

MSC 7770, Bethesda, MD 20892, (301) 435–

0695.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 9, 2001.

Time: 8:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Gaithersburg, 2

Montgomery Village Avenue, Gaithersburg,

MD 20879.

Contact Person: Gopal C. Sharma, DVM,

MS, PhD, Diplomate American Board of

Toxicology, Scientific Review Administrator,

Center for Scientific Review, National

Institutes of Health, 6701 Rockledge Drive,

Room 2184, MSC 7818, Bethesda, MD 20892,

(301) 435–1783, sharmag@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 9, 2001.

Time: 8:30 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 8120 Wisconsin

Avenue, Bethesda, MD 20814.

Contact Person: Joseph Kimm, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5178,

MSC 7844, Bethesda, MD 20892, (301) 435–

1249.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: March 9, 2001.

Time: 8:30 a.m. to 4:00 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Chevy Chase, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: Chhanda L. Ganguly, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5156,

MSC 7842, Bethesda, MD 20892, (301) 435–

1739.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333,

93.337, 93.393–93.396, 93.837–93.844,

93.846–93.878, 93.892, 93.893, National

Institutes of Health, HHS)

Dated: February 15, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–4441 Filed 2–22–01; 8:45 am]

BILLING CODE 4140–01–M